Phaseline

Targets › CNTF

CNTF (Ciliary neurotrophic factor): drug programs, companies and trials

1 program from 1 company in 2 trials: 2 Phase 2; Ophthalmology.

Functions as a cytokine through the ciliary neurotrophic factor receptor (CNTFR) complex. The CNTFR complex indeed consists of the membrane-anchored non-signaling receptor CNTFR and the two signaling receptor subunits IL6ST/gp130 and LIFR that transduce the signal into the cell. (UniProt, P26441)

Open in Phaseline: the race on CNTF, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Stanford UniversityNT-501 ECT implant
Encapsulated cell therapy delivering ciliary neurotrophic factor (CNTF)
CNTFPhase 2Glaucoma–

Conditions

Glaucoma (2)

Modalities

small molecule (1)

Companies

Stanford University (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.